These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11834722)

  • 1. Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins.
    David A; Mabjeesh N; Azar I; Biton S; Engel S; Bernstein J; Romano J; Avidor Y; Waks T; Eshhar Z; Langer SZ; Lifschitz-Mercer B; Matzkin H; Rotman G; Toporik A; Savitsky K; Mintz L
    J Biol Chem; 2002 May; 277(20):18084-90. PubMed ID: 11834722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
    Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
    Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4.
    Stephenson SA; Verity K; Ashworth LK; Clements JA
    J Biol Chem; 1999 Aug; 274(33):23210-4. PubMed ID: 10438493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen).
    Heuzé-Vourc'h N; Leblond V; Courty Y
    Eur J Biochem; 2003 Feb; 270(4):706-14. PubMed ID: 12581210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intron retention: a common splicing event within the human kallikrein gene family.
    Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
    Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein gene expression in human pituitary tissues.
    Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle.
    Hooper JD; Bui LT; Rae FK; Harvey TJ; Myers SA; Ashworth LK; Clements JA
    Genomics; 2001 Apr; 73(1):117-22. PubMed ID: 11352573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
    Yousef GM; Scorilas A; Jung K; Ashworth LK; Diamandis EP
    J Biol Chem; 2001 Jan; 276(1):53-61. PubMed ID: 11010966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
    Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
    Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling.
    Bridon DP; Dowell BL
    Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium.
    Clements J; Mukhtar A
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1536-9. PubMed ID: 7515392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
    Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
    Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4.
    Yousef GM; Luo LY; Diamandis EP
    Anticancer Res; 1999; 19(4B):2843-52. PubMed ID: 10652563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
    Lawrence MG; Lai J; Clements JA
    Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new human kallikrein gene family: implications in carcinogenesis.
    Diamandis EP; Yousef GM; Luo LY; Magklara A; Obiezu CV
    Trends Endocrinol Metab; 2000 Mar; 11(2):54-60. PubMed ID: 10675891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
    Lintula S; Stenman J; Bjartell A; Nordling S; Stenman UH
    Prostate; 2005 Jun; 63(4):324-9. PubMed ID: 15599939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
    Parikh H; Deng Z; Yeager M; Boland J; Matthews C; Jia J; Collins I; White A; Burdett L; Hutchinson A; Qi L; Bacior JA; Lonsberry V; Rodesch MJ; Jeddeloh JA; Albert TJ; Halvensleben HA; Harkins TT; Ahn J; Berndt SI; Chatterjee N; Hoover R; Thomas G; Hunter DJ; Hayes RB; Chanock SJ; Amundadottir L
    Hum Genet; 2010 Jan; 127(1):91-9. PubMed ID: 19823874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human kallikrein locus.
    Riegman PH; Vlietstra RJ; Suurmeijer L; Cleutjens CB; Trapman J
    Genomics; 1992 Sep; 14(1):6-11. PubMed ID: 1385301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very low PSA concentrations and deletions of the KLK3 gene.
    Rodriguez S; Al-Ghamdi OA; Burrows K; Guthrie PA; Lane JA; Davis M; Marsden G; Alharbi KK; Cox A; Hamdy FC; Neal DE; Donovan JL; Day IN
    Clin Chem; 2013 Jan; 59(1):234-44. PubMed ID: 23169475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.